{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:42:55Z","timestamp":1776303775058,"version":"3.50.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-89066"],"award-info":[{"award-number":["MOP-89066"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-111238"],"award-info":[{"award-number":["MOP-111238"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The range of genetic variation with potential clinical implications in schizophrenia, beyond rare copy number variants (CNVs), remains uncertain. We therefore analyzed genome sequencing data for 259 unrelated adults with schizophrenia from a well-characterized community-based cohort previously examined with chromosomal microarray for CNVs (none with 22q11.2 deletions). We analyzed these genomes for rare high-impact variants considered causal for neurodevelopmental disorders, including single-nucleotide variants (SNVs) and small insertions\/deletions (indels), for potential clinical relevance based on findings for neurodevelopmental disorders. Also, we investigated a novel variant type, tandem repeat expansions (TREs), in 45 loci known to be associated with monogenic neurological diseases. We found several of these variants in this schizophrenia population suggesting that these variants have a wider clinical spectrum than previously thought. In addition to known pathogenic CNVs, we identified 11 (4.3%) individuals with clinically relevant SNVs\/indels in genes converging on schizophrenia-relevant pathways. Clinical yield was significantly enriched in females and in those with broadly defined learning\/intellectual disabilities. Genome analyses also identified variants with potential clinical implications, including TREs (one in<jats:italic>DMPK<\/jats:italic>; two in<jats:italic>ATXN8OS<\/jats:italic>) and ultra-rare loss-of-function SNVs in<jats:italic>ZMYM2<\/jats:italic>(a novel candidate gene for schizophrenia). Of the 233 individuals with no pathogenic CNVs, we identified rare high-impact variants (i.e., clinically relevant or with potential clinical implications) for 14 individuals (6.0%); some had multiple rare high-impact variants. Mean schizophrenia polygenic risk score was similar between individuals with and without clinically relevant rare genetic variation; common variants were not sufficient for clinical application. These findings broaden the individual and global picture of clinically relevant genetic risk in schizophrenia, and suggest the potential translational value of genome sequencing as a single genetic technology for schizophrenia.<\/jats:p>","DOI":"10.1038\/s41398-021-01211-2","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T08:04:32Z","timestamp":1612166672000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Genome sequencing broadens the range of contributing variants with clinical implications in schizophrenia"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-9163","authenticated-orcid":false,"given":"Bahareh A.","family":"Mojarad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roozbeh","family":"Manshaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Backstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Costain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracy","family":"Heung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3728-4401","authenticated-orcid":false,"given":"Daniele","family":"Merico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0681-7279","authenticated-orcid":false,"given":"Anne S.","family":"Bassett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7273-4968","authenticated-orcid":false,"given":"Ryan K. C.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"1211_CR1","first-page":"1","volume":"5","author":"G Costain","year":"2012","unstructured":"Costain, G. & Bassett, A. S. Clinical applications of schizophrenia genetics: genetic diagnosis, risk, and counseling in the molecular era. Appl. Clin. Genet. 5, 1\u201318 (2012).","journal-title":"Appl. Clin. Genet."},{"key":"1211_CR2","first-page":"67","volume":"55","author":"TD Cannon","year":"1998","unstructured":"Cannon, T. D., Kaprio, J., L\u00f6nnqvist, J., Huttunen, M. & Koskenvuo, M. The genetic epidemiology of schizophrenia in a Finnish twin cohort: a population-based modeling study. JAMA Psychiatry 55, 67\u201374 (1998).","journal-title":"JAMA Psychiatry"},{"key":"1211_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nature13595","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics Consortium.","year":"2014","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421 (2014).","journal-title":"Nature"},{"key":"1211_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ng.3725","volume":"49","author":"CR Marshall","year":"2017","unstructured":"Marshall, C. R. et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat. Genet. 49, 27\u201335 (2017).","journal-title":"Nat. Genet."},{"key":"1211_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/nature08185","volume":"460","author":"International Schizophrenia Consortium.","year":"2009","unstructured":"International Schizophrenia Consortium. et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748\u2013752 (2009).","journal-title":"Nature"},{"key":"1211_CR6","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/ng.2446","volume":"44","author":"B Xu","year":"2012","unstructured":"Xu, B. et al. De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia. Nat. Genet. 44, 1365 (2012).","journal-title":"Nat. Genet."},{"key":"1211_CR7","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1001\/jamapsychiatry.2016.1831","volume":"73","author":"E Rees","year":"2016","unstructured":"Rees, E. et al. Analysis of intellectual disability copy number variants for association with schizophrenia. JAMA Psychiatry 73, 963\u2013969 (2016).","journal-title":"JAMA Psychiatry"},{"key":"1211_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/mp.2014.29","volume":"19","author":"SE McCarthy","year":"2014","unstructured":"McCarthy, S. E. et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol. Psychiatry 19, 652 (2014).","journal-title":"Mol. Psychiatry"},{"key":"1211_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.ajhg.2010.04.006","volume":"86","author":"DT Miller","year":"2010","unstructured":"Miller, D. T. et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet. 86, 749\u2013764 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"1211_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrneurol.2014.60","volume":"10","author":"A Poduri","year":"2014","unstructured":"Poduri, A., Sheidley, B. R., Shostak, S. & Ottman, R. Genetic testing in the epilepsies-developments and dilemmas. Nat. Rev. Neurol. 10, 293\u2013299 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"1211_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-018-0053-8","volume":"3","author":"MM Clark","year":"2018","unstructured":"Clark, M. M. et al. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases. npj Genom. Med. 3, 16 (2018).","journal-title":"npj Genom. Med."},{"key":"1211_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nrg2958","volume":"12","author":"C Alkan","year":"2011","unstructured":"Alkan, C., Coe, B. P. & Eichler, E. E. Genome structural variation discovery and genotyping. Nat. Rev. Genet. 12, 363\u2013376 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"1211_CR13","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrg1689","volume":"6","author":"CE Pearson","year":"2005","unstructured":"Pearson, C. E., Edamura, K. N. & Cleary, J. D. Repeat instability: mechanisms of dynamic mutations. Nat. Rev. Genet. 6, 729\u2013742 (2005).","journal-title":"Nat. Rev. Genet."},{"key":"1211_CR14","first-page":"864","volume":"54","author":"AS Bassett","year":"1994","unstructured":"Bassett, A. S. & Honer, W. G. Evidence for anticipation in schizophrenia. Am. J. Hum. Genet. 54, 864\u2013870 (1994).","journal-title":"Am. J. Hum. Genet."},{"key":"1211_CR15","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/YPG.0000000000000141","volume":"26","author":"JB Vincent","year":"2016","unstructured":"Vincent, J. B. Unstable repeat expansion in major psychiatric disorders: two decades on, is dynamic DNA back on the menu? Psychiatr. Genet. 26, 156\u2013165 (2016).","journal-title":"Psychiatr. Genet."},{"key":"1211_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13073-017-0488-z","volume":"9","author":"C Lowther","year":"2017","unstructured":"Lowther, C. et al. Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia. Genome Med. 9, 105\u2013105 (2017).","journal-title":"Genome Med."},{"key":"1211_CR17","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1093\/hmg\/ddt297","volume":"22","author":"G Costain","year":"2013","unstructured":"Costain, G. et al. Pathogenic rare copy number variants in community-based schizophrenia suggest a potential role for clinical microarrays. Hum. Mol. Genet. 22, 4485\u20134501 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"1211_CR18","doi-asserted-by":"publisher","unstructured":"Cleynen, I. et al. Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-020-0654-3 (2020 e-published).","DOI":"10.1038\/s41380-020-0654-3"},{"key":"1211_CR19","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41436-018-0260-9","volume":"21","author":"MS Reuter","year":"2019","unstructured":"Reuter, M. S. et al. Haploinsufficiency of vascular endothelial growth factor related signaling genes is associated with tetralogy of Fallot. Genet. Med. 21, 1001\u20131007 (2019).","journal-title":"Genet. Med."},{"key":"1211_CR20","unstructured":"The Genome Aggregation Database (gnomAD). https:\/\/gnomad.broadinstitute.org\/."},{"key":"1211_CR21","unstructured":"The Exome Aggregation Consortium (ExAC). https:\/\/exac.broadinstitute.org\/."},{"key":"1211_CR22","unstructured":"The International Genome Sample Resource (1000 Genomes Project). https:\/\/www.internationalgenome.org\/."},{"key":"1211_CR23","doi-asserted-by":"publisher","unstructured":"Collins, R.L. et al. An open resource of structural variation for medical and population genetics. bioRxiv https:\/\/doi.org\/10.1101\/578674 (2019).","DOI":"10.1101\/578674"},{"key":"1211_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405 (2015).","journal-title":"Genet. Med."},{"key":"1211_CR25","first-page":"947","volume":"66","author":"A Guilmatre","year":"2009","unstructured":"Guilmatre, A. et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation genes. JAMA Psychiatry 66, 947\u2013956 (2009).","journal-title":"JAMA Psychiatry"},{"key":"1211_CR26","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.tig.2009.10.004","volume":"25","author":"J Sebat","year":"2009","unstructured":"Sebat, J., Levy, D. L. & McCarthy, S. E. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet.: TIG 25, 528\u2013535 (2009).","journal-title":"Trends Genet.: TIG"},{"key":"1211_CR27","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/ejhg.2015.21","volume":"23","author":"L Damaj","year":"2015","unstructured":"Damaj, L. et al. CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms. Eur. J. Hum. Genet. 23, 1505\u20131512 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"1211_CR28","first-page":"213","volume":"4","author":"JE O\u2019Brien","year":"2013","unstructured":"O\u2019Brien, J. E. & Meisler, M. H. Sodium channel SCN8A (Nav1.6): properties and de novo mutations in epileptic encephalopathy and intellectual disability. Front. Genet. 4, 213 (2013).","journal-title":"Front. Genet."},{"key":"1211_CR29","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0887-8994(02)00624-0","volume":"28","author":"RM Carney","year":"2003","unstructured":"Carney, R. M. et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol. 28, 205\u2013211 (2003).","journal-title":"Pediatr. Neurol."},{"key":"1211_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajhg.2017.05.016","volume":"101","author":"A Lehman","year":"2017","unstructured":"Lehman, A. et al. Loss-of-function and gain-of-function mutations in KCNQ5 cause intellectual disability or epileptic encephalopathy. Am. J. Hum. Genet. 101, 65\u201374 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"1211_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajhg.2016.11.011","volume":"100","author":"K Yan","year":"2017","unstructured":"Yan, K. et al. Mutations in the chromatin regulator gene BRPF1 cause syndromic intellectual disability and deficient histone acetylation. Am. J. Hum. Genet. 100, 91\u2013104 (2017).","journal-title":"Am. J. Hum. Genet."},{"key":"1211_CR32","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1093\/hmg\/ddr122","volume":"20","author":"A Fassio","year":"2011","unstructured":"Fassio, A. et al. SYN1 loss-of-function mutations in autism and partial epilepsy cause impaired synaptic function. Hum. Mol. Genet. 20, 2297\u20132307 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1211_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/1252","volume":"19","author":"RH Wallace","year":"1998","unstructured":"Wallace, R. H. et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel \u00df1 subunit gene SCN1B. Nat. Genet. 19, 366 (1998).","journal-title":"Nat. Genet."},{"key":"1211_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1933","volume":"39","author":"CM Durand","year":"2006","unstructured":"Durand, C. M. et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39, 25 (2006).","journal-title":"Nat. Genet."},{"key":"1211_CR35","doi-asserted-by":"crossref","unstructured":"Giliberti, A. et al. MEIS2 gene is responsible for intellectual disability, cardiac defects and a distinct facial phenotype. Eur. J. Med. Genet. (2019).","DOI":"10.1016\/j.ejmg.2019.01.017"},{"key":"1211_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ejhg.2015.218","volume":"24","author":"A Ambalavanan","year":"2015","unstructured":"Ambalavanan, A. et al. De novo variants in sporadic cases of childhood onset schizophrenia. Eur. J. Hum. Genet. 24, 944 (2015).","journal-title":"Eur. J. Hum. Genet."},{"key":"1211_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature12929","volume":"506","author":"M Fromer","year":"2014","unstructured":"Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179\u2013184 (2014).","journal-title":"Nature"},{"key":"1211_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nrn2132","volume":"8","author":"N Tsankova","year":"2007","unstructured":"Tsankova, N., Renthal, W., Kumar, A. & Nestler, E. J. Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"1211_CR39","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.1093\/bioinformatics\/btz431","volume":"35","author":"E Dolzhenko","year":"2019","unstructured":"Dolzhenko, E. et al. ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions. Bioinformatics 35, 4754\u20134756 (2019).","journal-title":"Bioinformatics"},{"key":"1211_CR40","doi-asserted-by":"publisher","unstructured":"Tarjinder Singh, T.P., Curtis, D., Akil, H., Neale, B. M. & Daly M. J. On behalf of the Schizophrenia Exome Meta-Analysis (SCHEMA) Consortium. Exome sequencing identifies rare coding variants in 10 genes which confer substantial risk for schizophrenia. medRxiv https:\/\/doi.org\/10.1101\/2020.09.18.20192815 (2020).","DOI":"10.1101\/2020.09.18.20192815"},{"key":"1211_CR41","unstructured":"Yuen, R. K. et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat. Neurosci. 20, 602 (2017)."},{"key":"1211_CR42","doi-asserted-by":"crossref","unstructured":"Harper, P. S. Myotonic Dystrophy (Oxford University Press, 2009).","DOI":"10.1093\/oso\/9780199571970.001.0001"},{"key":"1211_CR43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/7710","volume":"21","author":"MD Koob","year":"1999","unstructured":"Koob, M. D. et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat. Genet. 21, 379\u2013384 (1999).","journal-title":"Nat. Genet."},{"key":"1211_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.schres.2011.06.017","volume":"132","author":"GM Khandaker","year":"2011","unstructured":"Khandaker, G. M., Barnett, J. H., White, I. R. & Jones, P. B. A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Res. 132, 220\u2013227 (2011).","journal-title":"Schizophrenia Res."},{"key":"1211_CR45","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/nn.4402","volume":"19","author":"G Genovese","year":"2016","unstructured":"Genovese, G. et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat. Neurosci. 19, 1433 (2016).","journal-title":"Nat. Neurosci."},{"key":"1211_CR46","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41593-019-0564-3","volume":"23","author":"DP Howrigan","year":"2020","unstructured":"Howrigan, D. P. et al. Exome sequencing in schizophrenia-affected parent\u2013offspring trios reveals risk conferred by protein-coding de novo mutations. Nat. Neurosci. 23, 185\u2013193 (2020).","journal-title":"Nat. Neurosci."},{"key":"1211_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature11011","volume":"485","author":"BM Neale","year":"2012","unstructured":"Neale, B. M. et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485, 242 (2012).","journal-title":"Nature"},{"key":"1211_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/gim.2016.54","volume":"19","author":"C Lowther","year":"2017","unstructured":"Lowther, C. et al. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Genet. Med. 19, 53\u201361 (2017).","journal-title":"Genet. Med."},{"key":"1211_CR49","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1093\/hmg\/ddq259","volume":"19","author":"E Vassos","year":"2010","unstructured":"Vassos, E. et al. Penetrance for copy number variants associated with schizophrenia. Hum. Mol. Genet. 19, 3477\u20133481 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"1211_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41586-020-2579-z","volume":"586","author":"B Trost","year":"2020","unstructured":"Trost, B. et al. Genome-wide detection of tandem DNA repeats that are expanded in autism. Nature 586, 80\u201386 (2020).","journal-title":"Nature"},{"key":"1211_CR51","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1469-8749.2012.04379.x","volume":"54","author":"M Douniol","year":"2012","unstructured":"Douniol, M. et al. Psychiatric and cognitive phenotype of childhood myotonic dystrophy type 1. Dev. Med. Child Neurol. 54, 905\u201311 (2012).","journal-title":"Dev. Med. Child Neurol."},{"key":"1211_CR52","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1017\/S0033291700035868","volume":"26","author":"MC O\u2019Donovan","year":"1996","unstructured":"O\u2019Donovan, M. C. et al. Confirmation of association between expanded CAG\/CTG repeats and both schizophrenia and bipolar disorder. Psychol. Med. 26, 1145\u20131153 (1996).","journal-title":"Psychol. Med."},{"key":"1211_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/nbdi.1995.0006","volume":"2","author":"K Lindblad","year":"1995","unstructured":"Lindblad, K. et al. Detection of expanded CAG repeats in bipolar affective disorder using the repeat expansion detection (RED) method. Neurobiol. Dis. 2, 55\u201362 (1995).","journal-title":"Neurobiol. Dis."},{"key":"1211_CR54","first-page":"385","volume":"53","author":"MG McInnis","year":"1993","unstructured":"McInnis, M. G. et al. Anticipation in bipolar affective disorder. Am. J. Hum. Genet. 53, 385\u2013390 (1993).","journal-title":"Am. J. Hum. Genet."},{"key":"1211_CR55","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41431-018-0114-6","volume":"26","author":"G Costain","year":"2018","unstructured":"Costain, G. et al. Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing. Eur. J. Hum. Genet. 26, 740\u2013744 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"1211_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WCO.0b013e32835ee548","volume":"26","author":"DM Werling","year":"2013","unstructured":"Werling, D. M. & Geschwind, D. H. Sex differences in autism spectrum disorders. Curr. Opin. Neurol. 26, 146\u2013153 (2013).","journal-title":"Curr. Opin. Neurol."},{"key":"1211_CR57","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/ng.3792","volume":"49","author":"HAF Stessman","year":"2017","unstructured":"Stessman, H. A. F. et al. Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases. Nat. Genet. 49, 515\u2013526 (2017).","journal-title":"Nat. Genet."},{"key":"1211_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/jamapsychiatry.2015.0346","volume":"72","author":"E Agerbo","year":"2015","unstructured":"Agerbo, E. et al. Polygenic risk score, parental socioeconomic status, family history of psychiatric disorders, and the risk for schizophrenia: a Danish population-based study and meta-analysis. JAMA Psychiatry 72, 635\u2013641 (2015).","journal-title":"JAMA Psychiatry"},{"key":"1211_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1146\/annurev-clinpsy-050817-084847","volume":"14","author":"R Bogdan","year":"2018","unstructured":"Bogdan, R., Baranger, D. A. A. & Agrawal, A. Polygenic risk scores in clinical psychology: bridging genomic risk to individual differences. Annu. Rev. Clin. Psychol. 14, 119\u2013157 (2018).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"1211_CR60","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219\u20131224 (2018).","journal-title":"Nat. Genet."},{"key":"1211_CR61","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/mp.2015.143","volume":"21","author":"KE Tansey","year":"2015","unstructured":"Tansey, K. E. et al. Common alleles contribute to schizophrenia in CNV carriers. Mol. Psychiatry 21, 1085 (2015).","journal-title":"Mol. Psychiatry"},{"key":"1211_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2015.12","volume":"1","author":"DJ Stavropoulos","year":"2016","unstructured":"Stavropoulos, D. J. et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom. Med. 1, 15012 (2016).","journal-title":"NPJ Genom. Med."},{"key":"1211_CR63","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1152\/physiolgenomics.00046.2018","volume":"50","author":"JW Prokop","year":"2018","unstructured":"Prokop, J. W. et al. Genome sequencing in the clinic: the past, present, and future of genomic medicine. Physiol. Genomics 50, 563\u2013579 (2018).","journal-title":"Physiol. Genomics"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01211-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01211-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T09:23:45Z","timestamp":1724405025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01211-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["1211"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01211-2","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Daniele Merico is a full-time employee of Deep Genomics Inc. and is entitled to a stock option. All other authors report no financial relationships with commercial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"84"}}